Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Drug-Related Side Effects and Adverse Reactions: early-phase trial registry
1 of 5 indexed Drug-Related Side Effects and Adverse Reactions trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Drug-Related Side Effects and Adverse Reactions: 5 US clinical trials tracked, 1 recruiting.
Drug-Related Side Effects and Adverse Reactions is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Abramson Cancer Center at Penn Medicine, running 2 of these trials.
Enrollment posture brief
Registry condition drug-related-side-effects-and-adverse-reactions
OPEN 1 | RECR 20% | LATE 0 | EARLY 1 | RANK #3391 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Drug-Related Side Effects and Adverse Reactions lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Drug-Related Side Effects and Adverse Reactions on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Drug-Related Side Effects and Adverse Reactions is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Drug-Related Side Effects and Adverse Reactions research.
Abramson Cancer Center at Penn Medicine accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.
-
Typical Drug-Related Side Effects and Adverse Reactions enrolment sits around 204 participants.
Median target enrolment is 204 among the 5 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.
-
Drug-Related Side Effects and Adverse Reactions research leans observational.
2 interventional and 3 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Eli Lilly and Company
NCT07169851
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer
Abramson Cancer Center at Penn Medicine
NCT05078190
Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer
Abramson Cancer Center at Penn Medicine
NCT05096338
The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial
VA Office of Research and Development
NCT02482025
DOAC ADRs Retrospective Study on Genetic Variations
Cipherome
NCT04580589
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Drug-Related Side Effects and Adverse Reactions records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Drug-Related Side Effects and Adverse Reactions trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Drug-Related Side Effects and Adverse Reactions page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Drug-Related Side Effects and Adverse Reactions trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Abramson Cancer Center at Penn Medicine sponsors the most Drug-Related Side Effects and Adverse Reactions trials on record, review their full trial history before evaluating a specific study. See Abramson Cancer Center at Penn Medicine's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Drug-Related Side Effects and Adverse Reactions condition card totals 5 registered trials; most-linked intervention Social Determinants of Health; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.